Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
ECTRIMS 2015 video update Teunissen: Progressive MS - how do we meet the therapeutic challenge?
jun 2017